In search of epileptic scalp high-frequency oscillations

Application of a convolutional neural network for fully-automated detection of spike ripples in the scalp electroencephalogram

BACKGROUND

A reliable biomarker to identify cortical tissue responsible for generating epileptic seizures is required to guide prognosis and treatment in epilepsy. Combined spike ripple events are a promising biomarker for epileptogenic tissue that currently require expert review for accurate identification. This expert review is time consuming and subjective, limiting reproducibility and high-throughput applications.

NEW METHOD

To address this limitation, we develop a fully-automated method for spike ripple detection. The method consists of a convolutional neural network trained to compute the probability that a spectrogram image contains a spike ripple.

RESULTS

We validate the proposed spike ripple detector on expert-labeled data and show that this detector accurately separates subjects with low and high seizure risks.

COMPARISON WITH EXISTING METHOD

The proposed method performs as well as existing methods that require manual validation of candidate spike ripple events. The introduction of a fully automated method reduces subjectivity and increases rigor and reproducibility of this epilepsy biomarker.

CONCLUSION

We introduce and validate a fully-automated spike ripple detector to support utilization of this epilepsy biomarker in clinical and translational work.

Neuromagnetic high frequency spikes are a new and noninvasive biomarker for localization of epileptogenic zones

OBJECTIVE

One barrier hindering high frequency brain signals (HFBS, >80 Hz) from wide clinical applications is that the brain generates both pathological and physiological HFBS. This study was to find specific biomarkers for localizing epileptogenic zones (EZs).

METHODS

Twenty three children with drug-resistant epilepsy and age/sex matched healthy controls were studied with magnetoencephalography (MEG). High frequency oscillations (HFOs, > 4 oscillatory waveforms) and high frequency spikes (HFSs, > 1 spiky or sharp waveforms) in 80-250 Hz and 250-600 Hz bands were blindly detected with an artificial intelligence method and validated with visual inspection. The magnitude of HFOs and HFSs were quantified with spectral analyses. Sources of HFSs and HFOs were localized and compared with clinical EZs determined by invasive recordings and surgical outcomes.

RESULTS

HFOs in 80-250 Hz and 250-600 Hz were identified in both epilepsy patients (18/23, 12/23, respectively) and healthy controls (6/23, 4/23, respectively). HFSs in 80-250 Hz and 250-600 Hz were detected in patients (16/23, 11/23, respectively) but not in healthy controls. A combination of HFOs and HFSs localized EZs for 22 (22/23, 96%) patients.

CONCLUSIONS

The results indicate, for the first time, that HFSs are a newer and more specific biomarker than HFOs for localizing EZs because HFOs appeared in both epilepsy patients and healthy controls while HFSs appeared only in epilepsy patients.